Results from the IMpower132 China cohort: Atezolizumab plus platinum-based chemotherapy in advanced non-small cell lung cancer

Lu, S; Fang, J; Wang, ZP; Fan, Y; Liu, YP; He, JX; Zhou, JY; Hu, J; Xia, JJ; Liu, WX; Shi, J; Yi, J; Cao, LJ

Lu, S (通讯作者)，Shanghai Chest Hosp, 241 West Huaihai Rd, Shanghai, Peoples R China.

CANCER MEDICINE, 2023; 12 (3): 2666

Abstract

Background The global Phase III IMpower132 study evaluating atezolizumab plus pemetrexed and carboplatin or cisplatin (APP) versus pemetrexed plus car......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索